Taiwain Researchers Report New Marker For Liver Cancer Risk
This article was originally published in PharmAsia News
Executive Summary
Taiwan scientists report discovery of a new biomarker for liver cancer, one related to the hepatitis B virus. The researchers said identifying the indicator could aid in new diagnostic procedures. The research, to be published in the next issue of the Journal of the National Cancer Institute, suggests a patient with genotype C has as much as double the risk of developing cancer as one with genotype B of the hepatitis B virus. Further, if the virus has mutated, the risk changes up or down according to where the mutation occurs. (Click here for more